Cargando…

DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease

Regulation of gene expression by epigenetic modifications means lasting and heritable changes in the function of genes without alterations in the DNA sequence. Of all epigenetic mechanisms identified thus far, DNA methylation has been of particular interest in both aging and age-related disease rese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazar, Volkan, Dawson, Valina L., Dawson, Ted M., Kang, Sung-Ung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041453/ https://www.ncbi.nlm.nih.gov/pubmed/36710687 http://dx.doi.org/10.3233/JPD-223517

Ejemplares similares

Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation
por: Yazar, Volkan, et al.
Publicado: (2021)

The cell biology of Parkinson’s disease
por: Panicker, Nikhil, et al.
Publicado: (2021)

c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential
por: Brahmachari, Saurav, et al.
Publicado: (2017)

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
por: Ge, Preston, et al.
Publicado: (2020)

The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
por: Karuppagounder, Senthilkumar S., et al.
Publicado: (2014)

The interplay of microRNA and neuronal activity in health and disease
por: Eacker, Stephen M., et al.
Publicado: (2013)

Waiting for PARIS—A Biological Target in Search of a Drug: PARIS farnesylation: Considerations in addressing a new biological target for neuroprotection in patients with Parkinson’s disease
por: Wyse, Richard K., et al.
Publicado: (2022)

Two approaches reveal a new paradigm of ‘switchable or genetics-influenced allele-specific DNA methylation’ with potential in human disease
por: Martos, Suzanne N, et al.
Publicado: (2017)

Pharmacologic inhibition of MIF nuclease: A new treatment paradigm to treat cell death
por: Biswas, Devanik, et al.
Publicado: (2022)

Targeting Parthanatos in Ischemic Stroke
por: Koehler, Raymond C., et al.
Publicado: (2021)

PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency
por: Pirooznia, Sheila K., et al.
Publicado: (2020)

Parthanatos Mediates AIMP2 Activated Age Dependent Dopaminergic Neuronal Loss
por: Lee, Yunjong, et al.
Publicado: (2013)

Quantitative mass spectrometric analysis of the mouse cerebral cortex after ischemic stroke
por: Agarwal, Ank, et al.
Publicado: (2020)

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily
por: Stafa, Klodjan, et al.
Publicado: (2014)

Recent advances in preventing neurodegenerative diseases
por: Chou, Shih-Ching, et al.
Publicado: (2021)

Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
por: Yin, Xiling, et al.
Publicado: (2021)

Neuronal Activity Regulates Hippocampal miRNA Expression
por: Eacker, Stephen M., et al.
Publicado: (2011)

Functional Identification of Neuroprotective Molecules
por: Dai, Cheng, et al.
Publicado: (2010)

MiR-223 regulates the differentiation of immature neurons
por: Harraz, Maged M, et al.
Publicado: (2014)

DNA Methylation Analysis in Monozygotic Twins Discordant for ALS in Blood Cells
por: Yazar, Volkan, et al.
Publicado: (2023)

Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
por: Xiong, Yulan, et al.
Publicado: (2017)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release
por: Yu, Seong-Woon, et al.
Publicado: (2009)

Neurons Derived from Human Induced Pluripotent Stem Cells Integrate into Rat Brain Circuits and Maintain Both Excitatory and Inhibitory Synaptic Activities
por: Yin, Xiling, et al.
Publicado: (2019)

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010)

Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons
por: Jiang, Haisong, et al.
Publicado: (2016)

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
por: Yun, Seung Pil, et al.
Publicado: (2018)

Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid
por: Na, Chan Hyun, et al.
Publicado: (2020)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
por: Yun, Seung Pil, et al.
Publicado: (2018)

Dysregulated DNA methylation in the pathogenesis of Fabry disease
por: Shen, Jin-Song, et al.
Publicado: (2022)

Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains
por: Kim, Jungwoo Wren, et al.
Publicado: (2021)

Implications of DNA Methylation in Parkinson’s Disease
por: Miranda-Morales, Ernesto, et al.
Publicado: (2017)

Placental DNA methylation signatures of maternal smoking during pregnancy and potential impacts on fetal growth
por: Everson, Todd M., et al.
Publicado: (2021)

T cells of Parkinson’s disease patients recognize α–synuclein peptides
por: Sulzer, David, et al.
Publicado: (2017)

High-Content Genome-Wide RNAi Screen Reveals CCR3 as a Key Mediator of Neuronal Cell Death
por: Zhang, Jianmin, et al.
Publicado: (2016)

Age-Related DNA Methylation Changes: Potential Impact on Skeletal Muscle Aging in Humans
por: Gensous, Noémie, et al.
Publicado: (2019)

Dynamic and redundant regulation of LRRK2 and LRRK1 expression
por: Biskup, Saskia, et al.
Publicado: (2007)

Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation
por: Thomas, Bobby, et al.
Publicado: (2011)

Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes
por: Gagné, Jean-Philippe, et al.
Publicado: (2008)

Correction: Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation
por: Thomas, Bobby, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cb6ofn5g4vd0egd3r2qepoc3nb